Delivery Order SPE2DB25D3012-SPE2DB25FWXPW
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,573.34 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This firm fixed-price, non-set-aside delivery order was awarded on June 16, 2025, with an ultimate completion date of June 17, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order represents a discrete transaction under a larger contract...
- The Defense Logistics Agency awarded a delivery order valued at $4,678.74 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This firm fixed-price, non-set-aside delivery order was awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,022.69. This firm fixed-price delivery order represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The insulin pens are to be...
- The Defense Logistics Agency awarded a delivery order valued at $4,543.88 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This competitively awarded, non-set-aside contract was established on August 12, 2025, with an ultimate completion date of August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a single pharmaceutical procurement...
- The Defense Logistics Agency awarded a delivery order valued at $2,001.20 to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This contract utilizes firm fixed price terms with an ultimate completion date of August 6, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $8,844.26 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, awarded on August 21, 2025, without a set-aside designation. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $3,173.46 to AmerisourceBergen Drug Corp for Novolog 100 Unit/ML FlexPen 3ML insulin pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $2,661.40 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This contract represents a competitive, non-set-aside award under a firm fixed-price arrangement with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- The Defense Logistics Agency awarded a $5,279.79 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens, with completion expected by September 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $7,027.17 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. The contract, issued on April 30, 2025, with an ultimate completion date of May 1, 2025, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWXPWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,198.70 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This firm fixed price, competitively awarded contract was executed on May 27, 2025, with an ultimate completion date of May 28, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office. No set-aside designation was applied to this award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide, including customers such as the Defense Health Agency and U.S. Coast Guard. The current delivery order represents a routine fulfillment of diabetes medication requirements within this broader framework of federal medical procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 5/27/25 |